Industry

SYDNEY–(BUSINESS WIRE)–#AI–Integrant today announced the formal publication of its proprietary “CTC Formula” in Chaos to Creation, (ISBN9798255688227) marking the first time the framework has been made accessible to the public, researchers, and the broader scientific community. Professor Gordon Slater, author of the book said, “We have been working closely with AI and blended real world … [Read more…]

LOS ANGELES, BOSTON & NEW YORK–(BUSINESS WIRE)–Two River, LLC (“Two River”) and Vida Ventures (“Vida”), both part of the Bellco Health ecosystem, today acknowledged the announced acquisition of Candid Therapeutics (“Candid”), a privately held clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), by UCB (Euronext: UCB), a … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will host an investor call on Monday, May 4, 2026 at 8:30 a.m. ET/5:30 a.m. PT to share topline results from the VISTAS study of volixibat in patients with primary sclerosing cholangitis (PSC). Conference Call Details: US/Toll-Free: + … [Read more…]

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune reset Candid’s lead asset, cizutamig, a bispecific antibody directed to B-cell maturation antigen (BCMA) on plasma cells and CD3 on T-cells, is currently in multiple phase 1 clinical studies across various autoimmune diseases Total … [Read more…]

The Milken Institute convenes its 29th annual Global Conference in Los Angeles, May 3–6 LOS ANGELES–(BUSINESS WIRE)–The Milken Institute’s 29th annual Global Conference opens today, May 3, 2026, and runs through May 6, 2026, at The Beverly Hilton and Waldorf Astoria Beverly Hills in Los Angeles. Held under the theme Leading in a New Era, … [Read more…]

The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology. Then bring your family. SALT LAKE CITY–(BUSINESS WIRE)–NomosLogic, Inc., the molecular medicine infrastructure company, today launched two new consumer experiences on Dendrite Lite, available now … [Read more…]

CHICAGO–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at the 106th American Association for Thoracic Surgery Annual Meeting. As evidence increasingly supports treating patients earlier in the valve disease pathway, the need for … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–#coffee–Laird Superfood, Inc. (NYSE American: LSF) will report financial results for the first quarter ended March 31, 2026 on Thursday, May 14, 2026 after market close. Management will host a webcast at 5:00 p.m. ET on the same day to discuss the results. Participants may access the live webcast on the Laird Superfood … [Read more…]

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi® (ruxolitinib) Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily Jakafi Jakafi XR will be available for pharmacy orders by May 8 WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) … [Read more…]

PHOENIX–(BUSINESS WIRE)–Outfront Health, a provider of physician-guided preventive health screenings, today announced the appointment of Dr. Shane Speirs, MD, MBA, as Chief Medical Officer (CMO). In this role, Dr. Speirs will lead clinical strategy, oversee screening protocols, and support the company’s expansion of non-invasive cardiovascular and stroke risk screening services. Dr. Speirs brings extensive experience … [Read more…]